|
|
|
|
 |
 |
Founded in 2004, Intezyne Technologies is a dynamic, innovative corporation devoted to addressing technological problems from an "integrated design" approach, incorporating a broad spectrum of scientific knowledge to develop the most functional and efficient solutions to the current limitations in drug delivery. By addressing these challenges from a different perspective, Intezyne is able to offer novel solutions to these scientific and medical challenges. Initially, Intezyne will focus on the area of biotechnology and specifically focusing on targeted drug delivery platforms. Intezyne's goal is to develop innovative, proprietary drug delivery vehicles with unsurpassed encapsulation versatility, specificity, and stability by utilizing a bottom-up approach of designing materials around the specific needs and requirements of each application.
PEOPLE
 |
 |
Habib Skaff, Ph.D.
Chief Executive Officer |
Kevin Sill, Ph.D.
Chief Science Officer |
|
|
|
|
